Sort
64,565 grants matching “drug discovery”
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
$1,349,670Linda C Giudice · University Of California, San Francisco · P01 · FY2023 · HD
Molecular Mechanisms Of Growth Control And Carcinogenesis
$1,349,334J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
GANESH (EMORY UNIVERSITY) - MCSP - HIT TO LEAD CHEMISTRY
$1,348,994Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2022 · DA
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
$1,348,453Denis Evseenko · University Of Southern California · R61 · FY2023 · NS
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,348,156Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
02 Research Animal Support Facility-Houston/Smithville
$1,347,608Vanessa Jensen · University Of Tx Md Anderson Can Ctr · P30 · FY2020 · CA
Role of CEBP transcription factors in regulating cell growth and tumorigenesis
$1,346,126Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Discovery to Implementation & Back: Research Translation for the HIV/SU Epidemic
$1,345,967Sherry Deren · New York University · P30 · FY2014 · DA
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology
$1,345,875Matthew D Disney · University Of Florida · R35 · FY2024 · NS
High throughput infrastructure for reaction screening and bioassays
$1,345,448Robert Graham Cooks · Purdue University · UH3 · FY2025 · TR
Optimization of HIV glycoproteins as vaccine candidates
$1,345,369Jose A Lasalde-Dominicci · University Of Puerto Rico · R01 · FY2017 · AI
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration
$1,345,312Joseph M Ready · Ut Southwestern Medical Center · RM1 · FY2022 · GM
Extramural Research Facilities Construction
$1,344,587University Of Pennsylvania · C06 · FY2005 · RR
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
$1,344,491Bruce M Psaty · University Of Washington · R01 · FY2014 · HL
Preclinical Development of HIV-1 Vif Antagonists
$1,344,436Mario Stevenson · Univ Of Massachusetts Med Sch Worcester · U19 · FY2007 · MH
Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease
$1,344,236Michael J Smanski · Metselex, Inc. · R42 · FY2023 · AG
Fox COBRE Phase II Admin Core
$1,343,022Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
Structural characterization of OM proteins from Gram-negative pathogens
$1,342,753Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Role of CEBP transcription factors in cell growth and tumorigenesis
$1,342,387Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$1,342,265Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium
$1,341,853Bruce M Psaty · University Of Washington · R01 · FY2012 · HL
Malaria Drug Resistance and Disease Virulence
$1,341,326Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
MEDIC-MicroED Imaging Center at UCLA
$1,341,283Tamir Gonen · University Of California Los Angeles · RM1 · FY2025 · GM
Natural Inhibitors of Carcinogenesis
$1,341,115John M Pezzuto · Purdue University · P01 · FY2009 · CA
Procurement and Characterization of Postmortem Brain Tissue
$1,340,978Joel Kleinman · National Institute Of Mental Health · ZIC · FY2010 · MH